EDWARDS LIFESCIENCES CORP

NYSE: EW (Edwards Lifesciences Corporatio)

Last update: 02 Jun, 1:29PM

77.92

-0.28 (-0.36%)

  • 1D -0.36%
  • 5D -4.71%
  • 1M -0.31%
  • 6M 13.70%
  • YTD 7.34%
  • 1Y 18.58%
  • 5Y -8.16%
Previous Close 78.20
Open 77.49
Volume 1,693,543
Avg. Volume (3M) 4,890,374
Market Cap 45,707,870,208
Price / Earnings (TTM) 32.20
Price / Earnings (Forward) 29.15
Price / Sales 8.34
Price / Book 4.47
52 Weeks Range
58.93 (-24%) — 95.25 (22%)
Earnings Date 22 Jul 2025 - 28 Jul 2025
Profit Margin 75.71%
Operating Margin (TTM) 29.01%
Diluted EPS (TTM) 2.42
Quarterly Revenue Growth (YOY) 6.20%
Quarterly Earnings Growth (YOY) 1.70%
Total Debt/Equity (MRQ) 6.86%
Current Ratio (MRQ) 4.45
Operating Cash Flow (TTM) 876.20 M
Levered Free Cash Flow (TTM) 1.45 B
Return on Assets (TTM) 8.42%
Return on Equity (TTM) 16.51%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Bearish Bearish
Medical Devices (Global) Bearish Bearish
Stock Edwards Lifesciences Corporatio Bullish Bullish

AIStockmoo Score

0.6
Analyst Consensus 3.0
Insider Activity NA
Price Volatility -3.5
Technical Moving Averages 1.0
Technical Oscillators 2.0
Average 0.63

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
EW 46 B - 32.20 4.47
BSX 159 B - 63.82 6.97
SYK 147 B 0.64% 51.04 7.09
PHG 26 B - 145.16 2.19
ABT 232 B 0.85% 17.33 4.58
MDT 113 B 2.37% 24.27 2.49

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Sector Healthcare
Industry Medical Devices
Investment Style Mid Growth
% Held by Insiders 0.91%
% Held by Institutions 89.29%
52 Weeks Range
58.93 (-24%) — 95.25 (22%)
Price Target Range
79.00 (1%) — 95.00 (21%)
High 95.00 (Stifel, 21.92%) Buy
95.00 (Barclays, 21.92%) Buy
95.00 (Mizuho, 21.92%) Buy
Median 88.00 (12.94%)
Low 79.00 (Baird, 1.39%) Hold
Average 87.23 (11.95%)
Total 7 Buy, 6 Hold
Avg. Price @ Call 79.60
Firm Date Target Price Call Price @ Call
Wells Fargo 07 Aug 2025 88.00 (12.94%) Buy 77.93
25 Jul 2025 84.00 (7.80%) Buy 80.00
Baird 25 Jul 2025 79.00 (1.39%) Hold 80.00
Barclays 25 Jul 2025 95.00 (21.92%) Buy 80.00
Canaccord Genuity 25 Jul 2025 81.00 (3.95%) Hold 80.00
Deutsche Bank 25 Jul 2025 94.00 (20.64%) Buy 80.00
Evercore ISI Group 25 Jul 2025 80.00 (2.67%) Hold 80.00
08 Jul 2025 77.00 (-1.18%) Hold 76.39
JP Morgan 25 Jul 2025 85.00 (9.09%) Hold 80.00
Mizuho 25 Jul 2025 95.00 (21.92%) Buy 80.00
16 Jul 2025 87.00 (11.65%) Buy 76.14
Piper Sandler 25 Jul 2025 90.00 (15.50%) Buy 80.00
RBC Capital 25 Jul 2025 89.00 (14.22%) Buy 80.00
Stifel 25 Jul 2025 95.00 (21.92%) Buy 80.00
Truist Securities 25 Jul 2025 82.00 (5.24%) Hold 80.00
Morgan Stanley 15 Jul 2025 81.00 (3.95%) Hold 76.81
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria